Search Results - "Peroni, Marianna"

A Simple Overview of Pancreatic Cancer Treatment for Clinical Oncologists by Garajová, Ingrid, Peroni, Marianna, Gelsomino, Fabio, Leonardi, Francesco

“…Pancreatic cancer (PDAC) is one of the most aggressive solid tumors and is showing increasing incidence. The aim of our review is to provide practical help for…”
Get full text

Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain? by Garajová, Ingrid, Gelsomino, Fabio, Salati, Massimiliano, Mingozzi, Anna, Peroni, Marianna, De Lorenzo, Stefania, Granito, Alessandro, Tovoli, Francesco, Leonardi, Francesco

“…The presence of actionable alterations in advanced biliary tract cancer patients opened new therapeutic possibilities for second-line treatments. However, for…”
Get full text

Directors' Duties in the European Initiative on Sustainable Corporate Governance: Implications for the Italian Legal System by Sacco, Maria Pia, Bagnato, Natalia, Giovine, Emiliano, Peroni, Marianna

“…In the last decade, the integration of sustainability factors in business conduct and corporate governance has come at the forefront of policy developments…”
Get full text

Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy by De Giglio, Andrea, Leonetti, Alessandro, Comito, Francesca, Filippini, Daria Maria, Mollica, Veronica, Rihawi, Karim, Peroni, Marianna, Mazzaschi, Giulia, Ricciotti, Ilaria, Carosi, Francesca, Marchetti, Andrea, Rosellini, Matteo, Gagliano, Ambrogio, Favorito, Valentina, Nobili, Elisabetta, Gelsomino, Francesco, Melotti, Barbara, Marchese, Paola Valeria, Sperandi, Francesca, Di Federico, Alessandro, Buti, Sebastiano, Perrone, Fabiana, Massari, Francesco, Pantaleo, Maria Abbondanza, Tiseo, Marcello, Ardizzoni, Andrea

“…Background Immune checkpoint inhibitors (ICIs) are standard treatments for advanced solid cancers. Resistance to ICIs, both primary and secondary, poses…”
Get full text

Liquid Biopsy and 18F-FDG PET/CT Derived Parameters as Predictive Factors of Osimertinib Treatment in Advanced EGFR-Mutated NSCLC by Leonetti, Alessandro, Cervati, Veronica, Minari, Roberta, Scarlattei, Maura, Verzè, Michela, Peroni, Marianna, Pluchino, Monica, Bonatti, Francesco, Perrone, Fabiana, Mazzaschi, Giulia, Cosenza, Agnese, Gnetti, Letizia, Bordi, Paola, Ruffini, Livia, Tiseo, Marcello

“…•Noninvasive predictors of 1L osimertinib outcome in EGFR-mutated NSCLC are needed.•Baseline ctDNA shedding was associated with poor osimertinib outcome.•Early…”
Get full text

Tissue Biomarkers in Gastric Cancer Treatment: Present and Future by Airò, Giulia, Agnetti, Virginia, Pratticò, Fabiana, Peroni, Marianna, Bui, Simona, Mura, Giovanni, Urbanowicz-Nijaki, Maria, Lai, Eleonora, Puzzoni, Marco, Contu, Fabiana, Denaro, Nerina, Scartozzi, Mario, Solinas, Cinzia, Tommasi, Chiara

“…The aggressive nature of gastric cancer often leads to late diagnosis and poor prognosis. Chemotherapy and the more recently added immunotherapy remain key…”
Get full text